pI: 6.5766 |
Length (AA): 2492 |
MW (Da): 271394 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 10 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
900 | 1546 | 1z3i (X) | 95 | 735 | 25.00 | 0 | 1 | 0.12 | -0.22 |
1271 | 1429 | 1fuk (A) | 235 | 385 | 18.00 | 0.000000000077 | 1 | 0.35 | -1.13 |
6 | 59 | 2kpy (A) | 56 | 108 | 26.00 | 0.058 | 0 | 0.288369 | -0.37 |
173 | 292 | 2mqa (A) | 20 | 138 | 10.00 | 0 | 0.02 | 0.125754 | -0.35 |
484 | 524 | 4x8w (H) | 1 | 209 | 51.00 | 0.41 | 0.06 | 0.214553 | 3.08 |
628 | 812 | 4o42 (A) | 270 | 439 | 28.00 | 0 | 0.94 | 0.226238 | 0.41 |
692 | 1520 | 3mwy (W) | 212 | 914 | 43.00 | 0 | 1 | 0.432765 | 1.2 |
958 | 1430 | 1z3i (X) | 145 | 640 | 36.00 | 0 | 1 | 0.550907 | -0.21 |
1271 | 1423 | 2hjv (A) | 216 | 363 | 22.00 | 0 | 1 | 0.394396 | -0.98 |
1964 | 2024 | 4b4c (A) | 1253 | 1320 | 46.00 | 0.00022 | 0.68 | 0.286578 | -0.44 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | VEG Tachyzoite, ME49 Tachyzoite. | Gregory |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | ME49 Oocyst, ME49 Bradyzoite. | Fritz HM Sibley/Greg |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | ME49 merozoite. | Hehl AB |
Fritz HM | Transcriptomic analysis of toxoplasma development reveals many novel functions and structures specific to sporozoites and oocysts. |
Gregory | ToxoDB |
Sibley/Greg | ToxoDB |
Hehl AB | Asexual expansion of Toxoplasma gondii merozoites is distinct from tachyzoites and entails expression of non-overlapping gene families to attach, invade, and replicate within feline enterocytes. |
Ortholog group members (OG5_128209)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT2G13370 | chromatin remodeling 5 |
Babesia bovis | BBOV_IV009080 | chromo-helicase DNA-binding protein, putative |
Brugia malayi | Bm1_28925 | Type III restriction enzyme, res subunit family protein |
Candida albicans | CaO19.10553 | transcriptional regulator |
Candida albicans | CaO19.3035 | transcriptional regulator |
Caenorhabditis elegans | CELE_H06O01.2 | Protein CHD-1 |
Cryptosporidium hominis | Chro.10413 | chromodomain-helicase-DNA-binding protein, CHD-1-related |
Cryptosporidium parvum | cgd1_3670 | CHD3 ortholog with 2x chromodomains plus SNF2 ATpase (2chromo+helicase+Znf_NFX) |
Dictyostelium discoideum | DDB_G0284171 | CHR group protein |
Drosophila melanogaster | Dmel_CG3733 | Chromodomain-helicase-DNA-binding protein 1 |
Echinococcus granulosus | EgrG_000760900 | chromodomain helicase DNA binding protein 1 |
Entamoeba histolytica | EHI_141900 | chromodomain-helicase-DNA-binding protein, putative |
Echinococcus multilocularis | EmuJ_000760900 | chromodomain helicase DNA binding protein 1 |
Giardia lamblia | GL50803_112978 | Chromodomain helicase-DNA-binding protein, putative |
Homo sapiens | ENSG00000173575 | chromodomain helicase DNA binding protein 2 |
Homo sapiens | ENSG00000153922 | chromodomain helicase DNA binding protein 1 |
Loa Loa (eye worm) | LOAG_04448 | hypothetical protein |
Mus musculus | ENSMUSG00000078671 | chromodomain helicase DNA binding protein 2 |
Mus musculus | ENSMUSG00000023852 | chromodomain helicase DNA binding protein 1 |
Neospora caninum | NCLIV_028160 | hypothetical protein |
Oryza sativa | 4344175 | Os07g0660200 |
Plasmodium berghei | PBANKA_0508100 | chromodomain-helicase-DNA-binding protein 1, putative |
Plasmodium falciparum | PF3D7_1023900 | chromodomain-helicase-DNA-binding protein 1 homolog, putative |
Plasmodium knowlesi | PKNH_0608400 | chromodomain-helicase-DNA-binding protein 1 homolog, putative |
Plasmodium vivax | PVX_111520 | hypothetical protein, conserved |
Plasmodium yoelii | PY02297 | chromodomain-helicase-DNA-binding protein, CHD-1-related |
Saccharomyces cerevisiae | YER164W | chromatin-remodeling ATPase CHD1 |
Schistosoma japonicum | Sjp_0000710 | ko:K01509 adenosinetriphosphatase [EC3.6.1.3], putative |
Schistosoma mansoni | Smp_041760 | chromodomain helicase DNA binding protein |
Schmidtea mediterranea | mk4.003381.01 | Putative chromodomain helicase DNA binding protein |
Schmidtea mediterranea | mk4.014198.00 | Putative chromodomain helicase DNA binding protein |
Toxoplasma gondii | TGME49_258240 | chromodomain helicase DNA binding protein CHD1/SWI2/SNF2 |
Theileria parva | TP01_0866 | hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
PBANKA_0508100 | Plasmodium berghei | Essential | plasmo |
TGME49_258240 this record | Toxoplasma gondii | Essentiality uncertain | sidik |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.